热致死调节针对性治疗治疗黑色素瘤的多个免疫细胞群体
Nicole A Wilski-Cronin1, Dan A Erkes1, Timothy J Purwin1
1Thomas Jefferson University, Philadelphia, PA, United States.
Cancer immunology research
|November 26, 2025
概括
加斯德明E (GSDME) 通过促进T细胞透来驱动抗黑色素瘤免疫力. 在黑色素瘤中,GSDME介导的热是有效的BRAF抑制剂加上MEK抑制剂治疗的关键.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
背景情况:
- BRAF 抑制剂加上 MEK 抑制剂 (BRAFi + MEKi) 通过激素灭绝增强抗黑色素瘤免疫力,这是一种通过气体皮质素 E (GSDME) 介导的细胞死亡过程.
- 通过GSDME影响瘤免疫力的确切机制尚不完全理解.
研究的目的:
- 调查GSDME在调节内免疫微环境中的作用,在黑色素瘤的BRAFi + MEKi治疗期间.
- 阐明GSDME如何影响免疫细胞透和功能,特别是调节性T细胞 (Tregs).
主要方法:
- 在黑色素瘤模型中使用单细胞RNA测序 (scRNA-seq) 和流细胞计.
- 使用了Gsdme淘汰赛 (KO) 和工程Gsdme突变黑色素瘤模型.
- 用BRAFi + MEKi治疗,单独和与TLR9激动剂结合使用.
主要成果:
- 与对照瘤相比,Gsdme KO瘤的T细胞,NK细胞和Tregs透率降低.
- 在Gsdme KO瘤中的Tregs显示了互白素-2受体和抑制标记物的表达减少.
- 在Gsdme缺陷模型中,用BRAFi + MEKi与TLR9激动剂相结合的黑色素瘤治疗抑制了瘤再生和进一步降低了内Tregs.
结论:
- 在用BRAFi+MEKi治疗的黑色素瘤中,GSDME在调节内免疫反应方面发挥着至关重要的作用.
- 通过 GSDME 介导的灭酶对于最佳的 T 细胞和 NK 细胞透和减少 Tregs.的抑制功能至关重要.
- 向GSDME或增强其功能可能是改善黑色素瘤对BRAFi + MEKi治疗反应的治疗策略.
相关概念视频
02:57Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
01:27Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
01:27Cytotoxic T Cells-mediated Immune Response
6.4K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.4K
02:50Combination Therapies and Personalized Medicine
5.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.8K